Stereotaxis Stock Performance
| STXS Stock | USD 2.42 0.05 2.11% |
On a scale of 0 to 100, Stereotaxis holds a performance score of 7. The entity has a beta of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Stereotaxis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Stereotaxis is expected to be smaller as well. Please check Stereotaxis' sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Stereotaxis' existing price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Stereotaxis are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Stereotaxis unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.72 | Five Day Return 10.08 | Year To Date Return 5.28 | Ten Year Return 45.23 | All Time Return (96.62) |
Last Split Factor 1096:1000 | Last Split Date 2013-11-04 |
1 | Stereotaxis earnings missed by 0.03, revenue topped estimates | 11/11/2024 |
2 | Earnings call Stereotaxis reports revenue growth in Q3, eyes future expansion | 11/12/2024 |
3 | Hospital in Portugal adopts Stereotaxis surgical robot | 11/20/2024 |
4 | Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China | 11/25/2024 |
5 | Stereotaxis GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems | 12/02/2024 |
6 | Magbot Robotic Magnetic Navigation Ablation Catheter Approved by Chinas NMPA | 12/09/2024 |
7 | Stereotaxis Stock Surges Amid Positive Ratings in Medical Device Sector | 12/13/2024 |
8 | Acquisition by Shamir Nachum of 45608 shares of Stereotaxis subject to Rule 16b-3 | 01/02/2025 |
9 | Ablation Devices Market Projected To Reach USD 24.98 Billion by 2032, Growing at a CAGR of 11.25 percent From 2024-2032 Introspective Market Research | 01/10/2025 |
10 | Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology | 01/14/2025 |
11 | Stereotaxis Announces First Genesisx Robotic System Order -January 30, 2025 at 0809 am EST - Marketscreener.com | 01/30/2025 |
| Begin Period Cash Flow | 9.9 M |
Stereotaxis |
Stereotaxis Relative Risk vs. Return Landscape
If you would invest 194.00 in Stereotaxis on November 2, 2024 and sell it today you would earn a total of 48.00 from holding Stereotaxis or generate 24.74% return on investment over 90 days. Stereotaxis is currently generating 0.4901% in daily expected returns and assumes 5.0638% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Stereotaxis, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Stereotaxis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stereotaxis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Stereotaxis, and traders can use it to determine the average amount a Stereotaxis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0968
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | STXS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.06 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.49 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Stereotaxis is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stereotaxis by adding it to a well-diversified portfolio.
Stereotaxis Fundamentals Growth
Stereotaxis Stock prices reflect investors' perceptions of the future prospects and financial health of Stereotaxis, and Stereotaxis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stereotaxis Stock performance.
| Return On Equity | -1.06 | ||||
| Return On Asset | -0.29 | ||||
| Profit Margin | (0.86) % | ||||
| Operating Margin | (0.69) % | ||||
| Current Valuation | 191.52 M | ||||
| Shares Outstanding | 84.73 M | ||||
| Price To Earning | 21.61 X | ||||
| Price To Book | 17.63 X | ||||
| Price To Sales | 7.99 X | ||||
| Revenue | 26.77 M | ||||
| Gross Profit | 14.12 M | ||||
| EBITDA | (21.24 M) | ||||
| Net Income | (20.71 M) | ||||
| Cash And Equivalents | 30.94 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 5.49 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 2.96 X | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (9.14 M) | ||||
| Earnings Per Share | (0.27) X | ||||
| Market Capitalization | 200.81 M | ||||
| Total Asset | 41.91 M | ||||
| Retained Earnings | (537.68 M) | ||||
| Working Capital | 20.02 M | ||||
| Current Asset | 17.14 M | ||||
| Current Liabilities | 16.14 M | ||||
About Stereotaxis Performance
Assessing Stereotaxis' fundamental ratios provides investors with valuable insights into Stereotaxis' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Stereotaxis is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 296.94 | 282.09 | |
| Return On Tangible Assets | (0.44) | (0.47) | |
| Return On Capital Employed | (0.69) | (0.65) | |
| Return On Assets | (0.44) | (0.47) | |
| Return On Equity | (0.85) | (0.89) |
Things to note about Stereotaxis performance evaluation
Checking the ongoing alerts about Stereotaxis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Stereotaxis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Stereotaxis had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 26.77 M. Net Loss for the year was (20.71 M) with profit before overhead, payroll, taxes, and interest of 14.12 M. | |
| Stereotaxis currently holds about 30.94 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Stereotaxis Announces First Genesisx Robotic System Order -January 30, 2025 at 0809 am EST - Marketscreener.com |
- Analyzing Stereotaxis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stereotaxis' stock is overvalued or undervalued compared to its peers.
- Examining Stereotaxis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stereotaxis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stereotaxis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stereotaxis' stock. These opinions can provide insight into Stereotaxis' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Stereotaxis Stock Analysis
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.